Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BioStock: Arcede approaching dosing in tox study

When reporting on first quarter of 2023, Arcede Pharma have an eventful period to look back on. Now all eyes are on the final part of the toxicology programme, where dosing starts in June. BioStock contacted CEO Mia Lundblad to hear her thoughts on the past quarter.Read the full article at biostock.se : https://www.biostock.se/en/2023/05/arcede-approaching-dosing-in-tox-study/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Crayfish BidCo Oy extends the offer period under the voluntary recommended cash tender offer for all shares in Caverion Corporation until 31 July 2023

Caverion Corporation   Tender Offer   17 May 2023 at 10.05 a.m. EESTCrayfish BidCo Oy extends the offer period under the voluntary recommended cash tender offer for all shares in Caverion Corporation until 31 July 2023 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE TENDER OFFER WOULD BE PROHIBITED BY APPLICABLE LAW. FOR FURTHER INFORMATION, PLEASE SEE SECTION ENTITLED “IMPORTANT INFORMATION” BELOW. On 10 January 2023, Crayfish

Gradientech: Interim report 1 January – 31 March 2023

Gradientech AB (publ) interim report for Q1 2023 is now available on the company's website www.gradientech.se.First quarter January-March 2023 · Net sales amounted to KSEK 380 (0). · Profit after tax amounted to KSEK -18,063 (-15,171). · Earnings per share before and after dilution were SEK -1.08 (-1.04). · Cash flow from operating activities amounted to KSEK -18,068 (-14,982). · Cash and cash equivalents on the balance sheet date amounted to KSEK 25,993 (74,020). · Equity as of March 31, 2023 amounted to KSEK 40,731 (78,598). · On January 18, 2023, the subscription

KPMG Iceland in collaboration with DecideAct: Efficient strategy implementation is the key to success

KPMG in Iceland and the software company DecideAct have signed a partnership agreement that will increase the level of service for KPMG Iceland's clients. The cooperation consists of, among other things, the results of strategic work and action plans that will be delivered ready for implementation in the DecideAct software.The strategy execution software has been developed for over 10 years and is a powerful solution for companies and organizations that want to ensure progress and effective strategy implementation. DecideAct is listed on the Nasdaq First North Growth Market in Denmark and

Valmet to supply consistency measurements to Norske Skog in France

Valmet Oyj’s trade press release on May 17, 2023 at 10:00 a.m. EESTValmet will supply consistency measurements to Norske Skog’s Golbey mill in France. The new measurements will be implemented in the new stock preparation unit and replace the aged ones from Golbey’s PM 1, which is currently being converted from the production of newsprint to the production of recycled containerboard. The order was included in Valmet’s orders received of the first quarter 2023. The measurements were delivered during the first quarter of 2023. The value of the order will not be disclosed. “We have

UPM Raflatac showcases its Graphics Solutions at FESPA Global Print Expo 2023

(UPM Raflatac, Helsinki, 17 May 2023 at 10:00 EEST) – UPM Raflatac, a global supplier of innovative and sustainable self-adhesive paper and film products, will showcase its graphics solutions at FESPA Global Print Expo 2023 in Munich, Germany on 23-26 May. UPM Raflatac will be participating in the expo for the first time under the Intercoat by UPM Raflatac brand name, after having acquired the AMC AG and the Intercoat brand in 2022. At their booth, UPM Raflatac will exhibit the UPM Raflatac Graphics Solutions, such as their PVC-free Eco Collection, Smart Apply Collection for fast and

Inify Laboratories AB (publ) – summary of Annual General Meeting

Inify Laboratories AB, corp. no. 559345-4431, held its ordinary Shareholders’ Annual General Meeting at the company's premises on May 16, 2023. A total of 34,075,774 shares were represented at the Annual General Meeting, corresponding to 75.3% of the total number of shares and votes. The AGM resolved, with the required majority, on all matters in accordance with the Board of Directors's published proposal. Below is a summary of the main decisions made, for further details please refer to the notice available on the company's website.   Adoption of the accounts The Annual General

Helsinki Paves the Way as a Forerunner of Circular Business when World Circular Economy Forum Returns Home

The circular economy has great potential at different stages of construction. The Helsinki Cluster Programme for Circular Economy carried out a reuse pilot at Katajanokka pier. It involved the transfer of usable furniture and materials from the demolition site to be reused elsewhere before the demolition work started. Photo: Kari Ylitalo The World Circular Economy Forum WCEF2023 will take place in Helsinki, Finland, from 30 May to 2 June 2023. The forum brings together the world's leading circular economy players to present and seek business and government solutions. It’s widely

BioStock: Aqilion – Disrupting the Vicious Cycle of Chronic Inflammation

Chronic inflammation is an underlying cause of many diseases and represents an immense societal burden. Researchers continue to struggle to solve the riddle behind this mechanism, and still treatments are lacking. Confronting the issue is the Swedish biotech Aqilion. BioStock spoke with the company's CEO Sarah Fredriksson to learn more about Aqilion’s vision and mission.Read the interview with Aqilion's CEO Sarah Fredriksson at biostock.se: Aqilion – Disrupting the Vicious Cycle of Chronic Inflammation - BioStock 

Carbiotix decides to scale up the production of CarbiAXOS from oat fiber

Carbiotix (publ) ("Carbiotix" or "Company") announces today that the Company has decided to scale up the production of CarbiAXOS from oat fiber at its production site in Bjuv. The oat fiber is supplied by The Green Dairy Sweden AB (“The Green Dairy”) based in Karlshamn, Sweden, and dried utilizing a technology provided by Elajo Technology Solutions AB (“Elajo”) based in Oskarshamn, Sweden. This decision to scale up the production of CarbiAXOS based on oats follows a successful 9-month evaluation project originally communicated on the 30th of March 2022. Successfully sourcing and upcycling

Dicot's study drug has arrived in Sweden

Press release: Uppsala, May 17, 2023. In preparation for Dicot's phase 1 clinical trial, the study drug to be used has now been manufactured by Thermo Fisher Scientific and arrived in Sweden.In February, the contract manufacturer Thermo Fisher Scientific began producing the study drug to be used when Dicot enters clinical trials with its potency drug candidate, which is planned for August this year. The manufacturing, done according to Good Manufacturing Practice, has now been completed and the study drug has arrived in Sweden. Study drug with active substance as well as matching placebo

Collaboration is key to creating a culture that supports children’s behaviour in early childhood education

When a child behaves in an unwanted manner, changing their behaviour often becomes a focus. Research, however, suggests that influencing the behaviour of adults who interact with the child would be more effective. Researchers at the University of Eastern Finland and the University of Jyväskylä conducted an 18-month follow-up of 18 Finnish early childhood education and care (ECEC) centres that were piloting positive behaviour intervention and support (PBIS), which takes a research-based approach to creating an operational culture that supports the behaviour of all children. The PBIS

BioStock: Zyneyro’s CEO on the collaboration with CombiGene

At the beginning of the year, CombiGene and Zyneyro entered into a collaboration for the development of new treatments for severe chronic pain conditions. The pain programme COZY consists of a peptide treatment and a gene therapy treatment. The gene therapy is reserved for patients where the possibilities for spontaneous reduction of the pain are considered excluded or unlikely. Zyneyro’s CEO Peter Horn Møller talks with BioStock about the collaboration and overall vision.Read the full interview with Peter Horn Møller at biostock.se: https://www.biostock.se/en/2023/05/zyneyros-ceo-on-the-

NOTICE OF ANNUAL SHAREHOLDERS’ MEETING IN INCOAX NETWORKS AB

The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail.    The shareholders of InCoax Network AB (publ), Reg. No. 556794-1363, are hereby invited to attend the annual shareholders’ meeting on Thursday 15 June 2023 09.00.Right to participate and notification  Shareholders wishing to participate in the annual shareholders’ meeting must:  · partly be listed in the company’s share register kept by Euroclear Sweden AB as of Wednesday 7 June 2023; and  · partly have given a

HC Andersen Capital Events 17/05: Meet the top management in Audientes & Scandinavian Medical Solutions

HC Andersen Capital is hosting digital events where you can meet and ask questions directly to the top management. It is free for all to attend.Audientes - Business updateAudientes updated its financial calendar on May 16th and this event will therefore be a business update. Audientes will publish its full-year report on 13 June 2023. Audientes has already announced their Q4 2022 results and decided not to announce any guidance for 2023 due to the uncertainty around the size of funding in the short-term, as well as in the medium term. Furthermore, the company has informed the market

Epiroc to purchase key assets in Australian mining equipment manufacturer

Stockholm, Sweden: Epiroc, a leading productivity and sustainability partner for the mining and infrastructure industries, has agreed to purchase the key assets of Schramm Australia, a leading manufacturer of products for reverse circulation (RC) drilling.Since February 2023, Schramm Australia, based in Perth, has been in voluntary administration, and Epiroc will now continue the business to the benefit of the customers. The assets include intellectual property as well as two production facilities near Perth and two service centers located in Queensland and South Australia. Schramm

The subscription period in Carbiotix AB´s issue of units starts today

Today, the 17th of May 2023, the subscription period in Carbiotix AB’s ("Carbiotix" or "Company") issue of units consisting of shares and free warrants of series TO2 (”TO 2”), with preferential rights for the Company's existing shareholders begins. The subscription period runs until the 2nd of June 2023. The issue volume initially amounts to a maximum of approximately SEK 12 million before transaction costs (the "Rights Issue"). Upon full subscription of the Rights Issue and full utilization of issued TO 2 at the highest subscription price, the Company may receive an additional approximately

Klimator AB (publ) Interim Report 1, January – March 2023

First quarter January 1 – March 31, 2023 Group · Operating income amounted to SEK 7,520K (SEK 5,594K) · Operating profit amounted to SEK -5,567K (SEK -6,052K) · Net profit after income taxes amounted to SEK -5,825K (SEK -6,135K) · Cash flow from current operations amounted to SEK -6 425K (-807K) · Number of shares as of March 31st amounted to 28 824 751 (13 400 000) · Net profit per share after income taxes amounted to SEK -0.20 (SEK -0.46)       (Amounts within parentheses refer to the corresponding figures for the same period the prior year) Material events

Scandinavian Enviro Systems (publ) publishes Annual Report 2022

Scandinavian Enviro Systems’ Annual Report for 2022 is as of today, Wednesday May 17 2023, available in Swedish on the company’s website https://envirosystems.se/investor/reports-presentations/.For further information, please contact:Thomas Sörensson, CEO Enviro, +46 (0)735-10 53 43, thomas.sorensson@envirosystems.seAlf Blomqvist, Chairman of the Board Enviro, +46 (0)733-14 97 00, alf@blomqvistunlimited.com Mangold Fondkommission AB is Enviro’s Certified Adviser on Nasdaq First North Growth Market Stockholm. Scandinavian Enviro Systems ABFrihamnen 16B, SE-417 70 Gothenburginfo@

The subscription price for the warrants of series TO3 in Wyld Networks AB has been determined to SEK 7.31 and the subscription period starts today, May 17, 2023

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE. In August 2021, Wyld Networks AB (“Wyld Networks” or the “Company”) entered a loan agreement. In connection with the procured loan Wyld Networks issued in total 2,275,000 warrants

Year-end report 1 April 2022 - 31 March 2023

Fourth quarter (1 January - 31 March 2023) · Net sales increased by 34 percent and amounted to SEK 5,267 million (3,916). · Operating profit before amortisation of intangible non-current assets (EBITA) increased by 47 percent and amounted to SEK 758 million (517) corresponding to an EBITA margin of 14.4 percent (13.2).  · Operating profit increased by 51 percent and amounted to SEK 660 million (436) corresponding to an operating margin of 12.5 percent (11.1). · Profit after tax increased by 42 percent and amounted to SEK 461 million (325) and earnings per share before dilution

Nordea cancels repurchased shares

Nordea Bank AbpStock exchange release – Total number of voting rights and capital17 May 2023 at 9.15 EET Nordea has today cancelled 6,558,616 treasury shares in line with the decision by the Board of Directors. The shares were held for capital optimisation purposes and acquired through share buy-backs. The cancellation brings the total number of shares in Nordea to 3,598,245,264. The total number of votes attached to the shares is 3,598,245,264. The cancellation of the shares was registered with the Finnish Trade Register on 17 May 2023. The company holds 1,265,819 treasury

Q1 2023 - Growth continues in the consulting industry

The trend of strong growth figures for Swedish and Finnish listed consulting firms continues during the first quarter. However, the growth is slowing down, and considering the high inflation, it is no longer particularly robust. The demand is generally good but highly differentiated.  The EBIT-margins are almost on par with last year. This is shown in the new infographic of the quarterly reports of the publicly listed consulting firms in Sweden and Finland.https://cinode.com/en/business-en/– During Q1, we observe a more differentiated consulting market. Companies with exposure to energy,

CS MEDICA A/S: Publication of Q2 2022/2023 report & invitation to live-streamed conference on May 24, at 10 AM CET

CS MEDICA (”CS MEDICA” or the ”Company”) hereby publishes its Q2 report for the period January – Marts 2023. Highlights of the Quarter will be presented at a live-streamed conference on Wednesday, May 24 at 10 AM CET. The Q2 report is available as an attached document to this press release and on the Company's website (www.cs-medica.com). Below is a summary of the report.Financial highlights for Q2 2022/2023 · In this second quarter of 2022/2023 (January – March 2023), CS MEDICA received orders corresponding to mDKK 1.9, which together with the orders from Q1, mDKK 1.1, total mDKK 3.0,

There are no items matching the current filter
There are no more items matching the current filter
Back to top